Persistence of epstein-barr virus in self-reactive memory B cells

Journal of Virology

Volumn 86, Issue 22, 2012, Pages 12330-12340

  Tracy, Sean I ^a   Kakalacheva, Kristina ^b   Lünemann, Jan D ^b   Luzuriaga, Katherine ^c   Middeldorp, Jaap ^d   Thorley Lawson, David A ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; LATENT MEMBRANE PROTEIN 1; LATENT MEMBRANE PROTEIN 2; VIRUS ANTIBODY;

ANTIGEN SPECIFICITY; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENE; GENETIC CODE; GERMINAL CENTER; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; LMP1 GENE; LMP2A GENE; MEMORY CELL; MOLECULAR CLONING; MULTIPLE SCLEROSIS; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS VIRULENCE;

ANTIBODIES; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS INFECTIONS; GENETIC VECTORS; HEK293 CELLS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOLOGIC MEMORY; LEUKOCYTES, MONONUCLEAR; RISK; SEQUENCE ANALYSIS, DNA; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4; MUS;

EID: 84869120227     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01699-12     Document Type: Article

References (41)

1. Alotaibi S, Kennedy J, Tellier R, Stephens D, Banwell B. 2004. Epstein-Barr virus in pediatric multiple sclerosis. JAMA 291:1875-1879.
2. Ascherio A, Munger KL. 2010. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Epstein-Barr virus and multiple sclerosis: epidemiological evidence. Clin. Exp. Immunol.160:120-124.
3. Ascherio A, Munger KL. 2007. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann. Neurol. 61:288-299.
4. Babcock GJ, Hochberg D, Thorley-Lawson AD. 2000. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 13:497-506.
5. Caldwell RG, Wilson JB, Anderson SJ, Longnecker R. 1998. Epstein- Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptorsignals. Immunity 9:405-411.
6. Casola S, et al. 2004. B cell receptor signal strength determines B cell fate. Nat. Immunol. 5:317-327.
7. Egner W. 2000. The use of laboratory tests in the diagnosis of SLE. J. Clin.Pathol. 53:424-432.
8. Gross AJ, Hochberg D, Rand WM, Thorley-Lawson DA. 2005. EBV and systemic lupus erythematosus: a new perspective. J. Immunol. 174:6599-6607.
9. Harley JB, Harley IT, Guthridge JM, James JA. 2006. The curiously suspicious: a role for Epstein-Barr virus in lupus. Lupus 15:768-777.
10. Harley JB, James JA. 2006. Epstein-Barr virus infection induces lupus autoimmunity. Bull. NYU Hosp. Jt. Dis. 64:45-50.
11. Heath E, et al. 2012. Epstein-Barr virus infection of naïve B cells in vitro frequently selects clones with mutated immunoglobulin genotypes: implications for virus biology. PLoS Pathog. 8:e1002697. doi:10.1371/journal.ppat.1002697.
12. Hershberg U, Uduman M, Shlomchik MJ, Kleinstein SH. 2008. Improved methods for detecting selection by mutation analysis of IgVregion sequences. Int. Immunol. 20:683-694.
13. Hochberg D, et al. 2004. Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells. J. Virol. 78:5194-5204.
14. James JA, et al. 1997. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J. Clin. Invest. 100:3019-3026.
15. James JA, et al. 2001. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum. 44:1122-1126.
16. Joseph AM, Babcock GJ, Thorley-Lawson DA. 2000. EBV persistence involves strict selection of latently infected B cells. J. Immunol. 165:2975-2981.
17. Khanna R, et al. 1997. Evolutionary dynamics of genetic variation in Epstein-Barr virus isolates of diverse geographical origins: evidence for immune pressure-independent genetic drift. J. Virol. 71:8340-8346.
18. Kulwichit W, et al. 1998. Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 95:11963-11968.
19. Kurth J, et al. 2000. EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency. Immunity 13:485-495.
20. Meij P, et al. 1999. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroupof patients with EBV-associated diseases. J. Infect. Dis. 179:1108-1115.
21. Pender MP. 2003. Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. Trends Immunol. 24:584-588.
22. Portis T, Longnecker R. 2004. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway. Oncogene 23:8619-8628.
23. Radic MZ, Weigert M. 1994. Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu. Rev. Immunol. 12:487-520.
24. Rickinson AB, Kieff E. 2001. Epstein-Barr virus, p 2575-2628. In Knipe DM, et al (ed), Fields virology, 4th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
25. Rothfield NF, Evans AS, Niederman JC. 1973. Clinical and laboratory aspects of raised virus antibody titres in systemic lupus erythematosus. Ann. Rheum. Dis. 32:238-246.
26. Roughan JE, Thorley-Lawson DA. 2009. The intersection of Epstein-Barr virus with the germinal center. J. Virol. 83:3968-3976.
27. Roughan JE, Torgbor C, Thorley-Lawson DA. 2010. Germinal center B cells latently infected with Epstein-Barr virus proliferate extensively but do not increase in number. J. Virol. 84:1158-1168.
28. Siemer D, et al. 2008. EBV transformation overrides gene expression patterns of B cell differentiation stages. Mol. Immunol. 45:3133-3141.
29. Souza TA, Stollar BD, Sullivan JL, Luzuriaga K, Thorley-Lawson DA. 2007. Influence of EBV on the peripheral blood memory B cell compartment. J. Immunol. 179:3153-3160.
30. Swanson-Mungerson M, Longnecker R. 2007. Epstein-Barr virus latent membrane protein 2A and autoimmunity. Trends Immunol. 28:213-218.
31. Swanson-Mungerson MA, Caldwell RG, Bultema R, Longnecker R. 2005. Epstein-Barr virusLMP2Aalters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen. J. Virol. 79:7355-7362.
32. Thorley-Lawson DA. 2001. Epstein-Barr virus: exploiting the immune system. Nat. Rev. Immunol. 1:75-82.
33. Thorley-Lawson DA, Gross A. 2004. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N. Engl. J. Med. 350:1328-1337.
34. Tiller T, et al. 2008. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J. Immunol. Methods 329:112-124.
35. + memory B cells. Immunity 26:205-213.
36. Uchida J, et al. 1999. Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses. Science 286:300-303.
37. Vrazo AC, Chauchard M, Raab-Traub N, Longnecker R. 2012. Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic mice. PLoS Pathog. 8:e1002662.doi:10.1371/journal.ppat.1002662.
38. Wang D, Liebowitz D, Kieff E. 1985. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831-840.
39. Wang H, et al. 2006. EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivity. J. Immunol. 177:2793-2802.
40. Wang X, Stollar BD. 2000. Human immunoglobulin variable region gene analysis by single cell RT-PCR. J. Immunol. Methods 244:217-225.
41. Wardemann H, et al. 2003. Predominant autoantibody production by early human B cell precursors. Science 301:1374-1377.